Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis. Issue 3 (March 2016)
- Record Type:
- Journal Article
- Title:
- Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis. Issue 3 (March 2016)
- Main Title:
- Correlation of spleen metabolism assessed by 18F-FDG PET with serum interleukin-2 receptor levels and other biomarkers in patients with untreated sarcoidosis
- Authors:
- Kalkanis, Alexandros
Kalkanis, Dimitrios
Drougas, Dimitrios
Vavougios, George D.
Datseris, Ioannis
Judson, Marc A.
Georgiou, Evangelos - Abstract:
- Abstract : Background: The objective of our study was to assess the possible relationship between splenic F-18-fluorodeoxyglucose ( 18 F-FDG) uptake and other established biochemical markers of sarcoidosis activity. Patients and methods: Thirty treatment-naive sarcoidosis patients were prospectively enrolled in this study. They underwent biochemical laboratory tests, including serum interleukin-2 receptor (sIL-2R), serum C-reactive protein, serum angiotensin-I converting enzyme, and 24-h urine calcium levels, and a whole-body combined 18 F-FDG PET/computed tomography (PET/CT) scan as a part of an ongoing study at our institute. These biomarkers were statistically compared in these patients. Results: A statistically significant linear dependence was detected between sIL-2R and log-transformed spleen-average standard uptake value (SUVavg ) ( R 2 =0.488, P <0.0001) and log-transformed spleen-maximum standard uptake value (SUVmax ) ( R 2 =0.490, P <0.0001). sIL-2R levels and splenic size correlated linearly (Pearson's r =0.373, P =0.042). Multivariate linear regression analysis revealed that this correlation remained significant after age and sex adjustment ( β =0.001, SE=0.001, P =0.024). No statistically significant associations were detected between (a) any two serum biomarkers or (b) between spleen-SUV measurements and any serum biomarker other than sIL-2R. Conclusion: Our analysis revealed an association between sIL-2R levels and spleen 18 F-FDG uptake and size, whereas allAbstract : Background: The objective of our study was to assess the possible relationship between splenic F-18-fluorodeoxyglucose ( 18 F-FDG) uptake and other established biochemical markers of sarcoidosis activity. Patients and methods: Thirty treatment-naive sarcoidosis patients were prospectively enrolled in this study. They underwent biochemical laboratory tests, including serum interleukin-2 receptor (sIL-2R), serum C-reactive protein, serum angiotensin-I converting enzyme, and 24-h urine calcium levels, and a whole-body combined 18 F-FDG PET/computed tomography (PET/CT) scan as a part of an ongoing study at our institute. These biomarkers were statistically compared in these patients. Results: A statistically significant linear dependence was detected between sIL-2R and log-transformed spleen-average standard uptake value (SUVavg ) ( R 2 =0.488, P <0.0001) and log-transformed spleen-maximum standard uptake value (SUVmax ) ( R 2 =0.490, P <0.0001). sIL-2R levels and splenic size correlated linearly (Pearson's r =0.373, P =0.042). Multivariate linear regression analysis revealed that this correlation remained significant after age and sex adjustment ( β =0.001, SE=0.001, P =0.024). No statistically significant associations were detected between (a) any two serum biomarkers or (b) between spleen-SUV measurements and any serum biomarker other than sIL-2R. Conclusion: Our analysis revealed an association between sIL-2R levels and spleen 18 F-FDG uptake and size, whereas all other serum biomarkers were not significantly associated with each other or with PET 18 F-FDG uptake. Our results suggest that splenic inflammation may be related to the systemic inflammatory response in sarcoidosis that may be associated with elevated sIL-2R levels. … (more)
- Is Part Of:
- Nuclear medicine communications. Volume 37:Issue 3(2016:Mar.)
- Journal:
- Nuclear medicine communications
- Issue:
- Volume 37:Issue 3(2016:Mar.)
- Issue Display:
- Volume 37, Issue 3 (2016)
- Year:
- 2016
- Volume:
- 37
- Issue:
- 3
- Issue Sort Value:
- 2016-0037-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-03
- Subjects:
- biomarkers -- interleukin-2 receptor -- PET scan -- sarcoidosis -- spleen
Nuclear medicine -- Periodicals
616.07575 - Journal URLs:
- http://journals.lww.com/nuclearmedicinecomm/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
http://www.lww.com/Product/0143-3636 ↗ - DOI:
- 10.1097/MNM.0000000000000431 ↗
- Languages:
- English
- ISSNs:
- 0143-3636
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6180.923000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 5108.xml